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Grand ChallenGes
The question of self–non-self discrimina-
tion, and thereby immunological toler-
ance, is as old as our appreciation of the 
receptor-diversity in the immune system. 
Initially  negative  selection  of  self-reac-
tive  lymphocytes  by  clonal  deletion  in 
primary lymphoid organs, enhanced by 
promiscuous expression of ectopic anti-
gens in these organs, attracted attention. 
It became clear, however, that such cen-
tral deletional mechanisms were some of 
many used to achieve non-responsiveness. 
Additional “recessive” mechanisms such as 
deletion and/or anergy in secondary lym-
phoid organs were also discovered, but it 
became clear that even these additional 
passive mechanisms were insufficient to 
account for self-tolerance and that “domi-
nant” immunoregulation played a major, 
indeed essential, role. The discovery of the 
transcription factor Foxp3, as the master 
switch enabling regulation, has led to the 
identification  of  Foxp3  expressing  cells 
whose sole role is suppression of the func-
tions of other adaptive and innate immune 
cells.
These facts make it necessary to study 
the mechanisms of immunological toler-
ance at the cellular and molecular level in 
general, and the development, activation 
and effector function of regulatory Tcells 
in particular, with the same intensity as has 
been applied to investigating immunity to 
foreign antigens. Once the fine details of 
tolerance are understood we should be in a 
better position to study how tolerance fails 
in autoimmune diseases, and to develop 
new ways of reprogramming the immune 
system so as to amplify tolerance mecha-
nisms  in  autoimmunity,  transplantation 
and allergy, and to override them to boost 
immunity to cancer. Thus the goals for the 
future are the understanding of self–non-
self discrimination at the mechanistic level, 
as well as application of the knowledge to 
achieve a better understanding of human 
disease and its rational treatments.
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